Jessup, MD, United States of America

Glenn M Swartz, Jr


Average Co-Inventor Count = 4.0

ph-index = 5

Forward Citations = 267(Granted Patents)


Location History:

  • Laurel, MD (US) (1989)
  • Jessup, MD (US) (1998 - 2009)

Company Filing History:


Years Active: 1989-2009

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Glenn M Swartz, Jr.

Introduction

Glenn M Swartz, Jr. is a notable inventor based in Jessup, MD (US), recognized for his significant contributions to the field of medical science. He holds a total of 7 patents, showcasing his innovative spirit and dedication to advancing healthcare solutions.

Latest Patents

Among his latest patents is a groundbreaking invention titled "Methods and compositions for treating an ocular neovascular disease." This invention comprises a group of compounds that effectively inhibit angiogenesis, specifically focusing on the compound EM-138 and its application in inhibiting tumor growth and metastasis. Another notable patent is for "Analogs of 2-Phthalimidinoglutaric acid," which provides new and useful analogs, including DL-2-methyl-2-phthalimidinoglutaric acid and its hydroxylated variants. This invention also details processes for making these analogs and methods for treating angiogenesis-associated diseases, such as cancer and macular degeneration.

Career Highlights

Throughout his career, Glenn has worked with prominent organizations, including Entremed, Inc. and Children's Medical Center Corporation. His work in these institutions has contributed to the development of innovative medical treatments and therapies.

Collaborations

Glenn has collaborated with esteemed colleagues, including John W Madsen and Shawn J Green, further enhancing the impact of his inventions through teamwork and shared expertise.

Conclusion

Glenn M Swartz, Jr. exemplifies the spirit of innovation in the medical field, with his patents paving the way for advancements in treatment options for serious health conditions. His contributions continue to inspire future generations of inventors and researchers.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…